GENNIEFY
Market News
Latest financial news and analysis from global markets
MRK
Is Merck (MRK) Still Attractive After Recent Pullback And Conflicting Valuation Signals
Wondering whether Merck’s current share price reflects its real value, or if the stock might be pricing in more than it should. Merck closed at US$113.15, with returns of 2.8% over 7 days, a 6.4% decline over 30 days, 6.3% year to date and 48.4% over the last year. Recent headlines around Merck have kept investors focused on how the company is being priced, with attention on its long term prospects and capital allocation decisions. This context helps explain why the stock’s recent moves have...
PEP
Subway rolls out poppi prebiotic sodas across US outlets
The restaurant chain has introduced two poppi variants nationwide.
PFE
A Look At Pfizer (NYSE:PFE) Valuation After Q1 2026 Beat And Pipeline Progress
Pfizer (PFE) is back in focus after reporting first quarter 2026 results that topped analyst expectations, reaffirmed its full year guidance, and paired those figures with fresh product, legal and regulatory updates. See our latest analysis for Pfizer. Despite the earnings beat and a series of product, legal and regulatory updates in oncology and rare disease, market reaction has been measured, with a year to date share price return of 5.04% and 1 year total shareholder return of 23.99%. This...
GOOGL
Anthropic’s US$200b Deal Puts Alphabet At Center Of AI Infrastructure
Anthropic has committed to spend about US$200b on Google Cloud services over five years, according to new disclosures in the past week. This commitment represents over 40% of Alphabet's existing Google Cloud revenue backlog. Google Cloud reported 63% revenue growth and Alphabet plans to sell its custom AI chips, TPUs, directly to customers. These moves position Alphabet (NasdaqGS:GOOGL) as a full stack provider for generative AI, from infrastructure to model delivery. For you as an...
AAPL
US Supreme Court declines to pause order holding Apple in contempt in Epic Games lawsuit
Justice Elena Kagan, on behalf of the court, declined to pause a ruling by the San Francisco-based 9th U.S. Circuit Court of Appeals that deemed Apple in contempt in the Epic lawsuit contesting App Store fees. Apple had sought the delay to give it time to file a full Supreme Court appeal of the 9th Circuit decision.
UNH
CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
CVS stock is breaking out on Wednesday morning after it posted better-than-expected first-quarter results and raised its full-year outlook. Of CVS Health's three big segments, its health benefits segment saw operating income surge by $1.05 billion, or 53%.
NVDA
CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
The CBOE Volatility Index (^VIX) is drifting back toward the 17 line as optimism returns to the S&P 500 and capital rotates into stocks. The VIX closed near 18 on Monday after dipping to almost 17 late last week, well below the peak above 31 recorded in late March. In a display of a shifting ... CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
INTC
CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
The CBOE Volatility Index (^VIX) is drifting back toward the 17 line as optimism returns to the S&P 500 and capital rotates into stocks. The VIX closed near 18 on Monday after dipping to almost 17 late last week, well below the peak above 31 recorded in late March. In a display of a shifting ... CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
AMD
CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
The CBOE Volatility Index (^VIX) is drifting back toward the 17 line as optimism returns to the S&P 500 and capital rotates into stocks. The VIX closed near 18 on Monday after dipping to almost 17 late last week, well below the peak above 31 recorded in late March. In a display of a shifting ... CBOE VIX Slides Toward 17 as Oil Retreat and Tech Stock Surge Restore Risk Appetite
NVDA
SRET’s Monthly Payouts Survive Global Real Estate Stress, Data Shows
Global X SuperDividend REIT ETF (NYSEARCA:SRET) holds roughly 30 of the highest-yielding REITs worldwide, equally weighted, with monthly distributions. SRET investors own this fund primarily for the income stream, which raises a fair question: Can SRET keep paying as global real estate shifts under higher-for-longer rates, weakening consumer sentiment, and operator stress in healthcare and ... SRET’s Monthly Payouts Survive Global Real Estate Stress, Data Shows
AMD
AMD (AMD) Q1 2026 Earnings Call Transcript
Lisa Su: Thank you, Matt, and good afternoon to all those listening in today. Growth was broad-based with every segment increasing year-over-year, led by 57% data center revenue growth. Data center is now the primary driver of our revenue and earnings growth.
ABBV
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
Biotech stock Avalo Therapeutics skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment.